Adverse events80

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 60 of 80

Type	Event	Organ system	Group	Affected	At risk	Events
other	Urticaria	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Scoliosis	Musculoskeletal and connective tissue disorders	Onasemnogene Abeparvovec-xioi	9	22	12
other	Deformity thorax	Musculoskeletal and connective tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Joint contracture	Musculoskeletal and connective tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Kyphosis	Musculoskeletal and connective tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Torticollis	Musculoskeletal and connective tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Feeding disorder	Metabolism and nutrition disorders	Onasemnogene Abeparvovec-xioi	3	22	4
other	Weight gain poor	Metabolism and nutrition disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Upper respiratory tract infection	Infections and infestations	Onasemnogene Abeparvovec-xioi	11	22	28
other	Conjunctivitis	Infections and infestations	Onasemnogene Abeparvovec-xioi	3	22	3
other	Otitis media	Infections and infestations	Onasemnogene Abeparvovec-xioi	3	22	4
other	Respiratory syncytial virus bronchiolitis	Infections and infestations	Onasemnogene Abeparvovec-xioi	2	22	3
other	Gastroenteritis	Infections and infestations	Onasemnogene Abeparvovec-xioi	2	22	2
other	Nasopharyngitis	Infections and infestations	Onasemnogene Abeparvovec-xioi	2	22	2
serious	Alanine aminotransferase increased	Investigations	Onasemnogene Abeparvovec-xioi	1	22	1
serious	Aspartate aminotransferase increased	Investigations	Onasemnogene Abeparvovec-xioi	1	22	1
serious	Human metapneumovirus test positive	Investigations	Onasemnogene Abeparvovec-xioi	1	22	1
serious	Transaminases increased	Investigations	Onasemnogene Abeparvovec-xioi	1	22	1
serious	Cyanosis	Cardiac disorders	Onasemnogene Abeparvovec-xioi	1	22	1
serious	Respiratory distress	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	4	22	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03306277/events?page=3

API reference For AI assistants